Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.

Health & Wellness

Biotechnology

Annexon Biosciences

Douglas Love

Jamie Dananberg

Ranjith K.

Peter Collins

Ping Lin

Kunal Kanani

John Hanna

Henk-Andre Kroon

Dean Richard Artis

Cecilia Oliyai

Behn Sarafpour

AJ Acker

Rick Artis

Jennifer Lew

Michael Overdorf

Ted Yednock

Clinical Development and Operations

Leadership Team

Teams at Annexon Biosciences

Clinical Development and Operations

Leadership Team